###begin article-title 0
###xml 47 52 <span type="species:ncbi:9606">human</span>
Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study
###end article-title 0
###begin p 1
Responsible Editor: A. Falus.
###end p 1
###begin title 2
Objective
###end title 2
###begin p 3
###xml 33 38 <span type="species:ncbi:9606">human</span>
 Previous research suggests that human basophil activation may be inhibited by histamine even at extremely low doses (high dilutions). However, uncertainties about the nature of the phenomenon and its reproducibility mean that further, rigorously controlled studies are necessary.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;20</sup>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;32</sup>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 512 516 <span type="species:ncbi:9925">goat</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
 Serial 1:100 (v:v) histamine dilutions (centesimal dilutions, C) and water controls were tested on human basophil responsiveness to anti-IgE antibodies, using flow cytometry. Each dilution step was followed by vertical mechanical shaking (also designed as succussion) at 20 strokes/s. Basophil-enriched buffy coats from healthy blood donors were incubated with 10-4 mol/l histamine (2C) and with serially diluted preparations from 10-20 mol/l (10C) to 10-32 mol/l (16C), then incubated for 30 min with 1 mug/ml goat monoclonal anti-human IgE and basophils stained for immunophenotyping.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Membrane up-regulation of CD203c, which in these experimental conditions proved to be a more consistent activation marker than CD63, was significantly inhibited in samples treated with histamine at the dilutions of 2C (P = 0.001), 12C (P = 0.047), 14C (P = 0.003), 15C (P = 0.036) and 16C (P = 0.009). Control water dilutions/succussions did not show any significant effect.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Using a strictly standardized flow cytometry protocol and a new dilution/succussion procedure, we have shown that low and high dilutions of histamine inhibit CD203c up-regulation in anti-IgE stimulated basophils.
###end p 9
###begin title 10
Keywords
###end title 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nature</italic>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1238 1241 1238 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;10</sup>
###xml 1283 1286 1283 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;38</sup>
###xml 1326 1327 1326 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 1328 1329 1328 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1603 1605 1603 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1805 1807 1805 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 2035 2037 2035 2037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 2039 2041 2039 2041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 2087 2089 2087 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 2091 2093 2091 2093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 2177 2179 2177 2179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 2355 2357 2355 2357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 2461 2463 2461 2463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 2894 2897 2894 2897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;32</sup>
###xml 2920 2922 2920 2922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 2957 2959 2957 2959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 3008 3010 3008 3010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 358 363 <span type="species:ncbi:9606">human</span>
In the past 20 years, many laboratory studies on cell [1] and animal [2] models have sought to test the pharmacological effects of dilutions which statistically contain very few or no molecules of active principle. The most widely investigated high-dilution effect has been the regulation of basophil leukocytes. A prominent multicentre study [3] found that human basophils underwent "degranulation" (detected as cell metachromasia) not only at the usual anti-IgE antibody doses (10-3 mg/ml), but also at extremely high dilutions of antibody ("sub-molecular" doses). This work was published in the journal "Nature" and had considerable resonance as a presumed demonstration of "water memory", but was heavily criticized on theoretical grounds and due to the difficulty of reproducing the results [4-6]. Although this particular model was not followed up by further replication studies, there has been extensive research on basophil response to highly diluted substances focused on the effects of histamine. Several authors report the inhibition of basophil "degranulation", evaluated by optical microscopy of cells stained with alcian or toluidine blue, using high dilutions of pure histamine at theoretical concentrations ranging from 10-10 mol/l (5th centesimal dilution, 5C) to 10-38 mol/l (19th centesimal dilution, 19C) [7-9]. The high-dilution effect of histamine has also been confirmed in a multicentre trial [10], although the authors report that not all the laboratories involved were able to observe the phenomenon, possibly due to variations in basophil sensitivity depending on the donors [11]. Controversies over the manual method used to assess basophil activation, along with its time-consuming and subjective nature, prompted adoption of a standardized automated flow cytometry approach [12], which was able to evaluate the effect of highly diluted compounds by quantitatively following membrane expression of the investigated cells. More recently, similar effects have been confirmed by two independent laboratories [13, 14] and by the group of Belon and Sainte-Laudy [15, 16], who also report that CD203c is the most suitable marker for this type of effect [17]. However, the literature in this field is not always consistent, with some experiments showing that highly diluted histamine activates rather than inhibiting the same cells [18], while another group failed to replicate the reported inhibitory effects of high histamine dilutions [19]. These last-mentioned authors suggest that minor variables of the experimental set-up, such as the placement of samples in different rows on the same laboratory microplate, may produce significant differences in the results if not properly controlled (though it is worth noting that most flow cytometry experiments performed by the other authors were done using disposable tubes). Finally, a number of studies have used only a 10-32 mol/l solution (16C) [16], or a pool of several dilutions [10], but dose-response curves are rarely reported [13].
###end p 12
###begin p 13
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
Notwithstanding the prevailing evidence in favor of a true "high-dilution effect", the implausibility of such claims calls for serious investigation into the possibility of artifacts, arising from as-yet unidentified methodological factors, also because the research in this field has until now failed to account for the discrepancies observed between different laboratories. Even where many experiments of high methodological standard have demonstrated an effect of high dilutions, there has been no positive result stable enough to be reproduced by all investigators [20-24]. Therefore, given the profound pharmacological and biological implications of high-dilution effects, further independent replications, under rigorously controlled experimental conditions, are needed [25].
###end p 13
###begin p 14
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
The aim of this study was to further investigate the effects of histamine on human basophils in vitro, using a new polychromatic flow cytometry protocol to quantify membrane expression of basophil activation markers [26]. Cell activation or inhibition were detected by the mean fluorescence intensity (MFI) of CD203c, a membrane ectoenzyme which represents the most sensitive IgE-specific basophil activation marker [26-28], and by the percentage of cells which up-regulated CD63, a molecule which is associated to the lysosomes and is involved in degranulation events [29]. Basophil activation results in a dose-dependent increase in CD203c MFI, while expression of CD63 is an all-or-nothing phenomenon which occurs at relatively higher doses of stimuli and exhibits bimodal distribution [26, 30], with one peak of highly positive cells (being the FITC fluorochrome highly fluorescent) and another one of fully negative cells. This is the reason why most researchers prefer to evaluate CD63 up-regulation not by the MFI, but by the percentage of cells that express the marker compared to the non-expressing resting state [11-16].
###end p 14
###begin p 15
###xml 293 295 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 436 439 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;23</sup>
Here, we report the results of a series of experiments, in which particular care was taken with the following technical details: (a) to create favorable conditions for the putative inhibitory effects of histamine, cells were activated using a relatively low dose of anti-IgE, namely 1 mug/ml [26]; (b) both low (2C) and high (10C to 16C) dilutions of histamine were tested, thus in a range encompassing the Avogadro constant (6.022 x 10-23 mol/l); (c) each dilution step involved a 100 x decrease in concentration, and was followed by vigorous mechanical agitation ("succussion" according to homeopathic pharmacopoeia) in a shaking machine commonly used in pharmaceutical practice; (d) all the assays were performed in triplicate tubes in sterile conditions and using disposable plasticware to decrease the risk of cross-contamination; (e) ultrapure distilled water was used as a solvent, and a series of succussed dilutions of pure water were run to control for artifacts arising from the procedures or the materials employed; (f) in order to test the two main variables, namely CD203c MFI and percentage of CD63 positive (bright) cells, we used quantitative analyses and objective evaluations, a procedure that makes performing experiments in blinded fashion less necessary as it would be when performing the optical detection of basophil degranulation.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin title 17
Reagents and disposable ware
###end title 17
###begin p 18
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 412 416 <span type="species:ncbi:9925">goat</span>
4-(2-Hydroxyethyl)piperazine-1-ethanesulonic acid (HEPES), sodium heparine 170 U/mg, histamine dihydrochloride, and salts were purchased from Sigma-Aldrich, GmbH, Germany. Water used for stock solution and dilutions was purchased from Sigma-Aldrich as HPLC-grade water (Chromasolv plus) (< 0.001% non-volatile matter). Histamine dihydrochloride was prepared as a stock solution of 0.4 mol/l in water. Anti-human goat monoclonal IgE was sourced from Caltag, USA. Anti-CD203c-PE (isotype IgG1, clone 97A6) was purchased from Beckman Coulter Immunotech, USA, anti-CD123-PECy5 (isotype IgG1, clone 9F5), anti-HLA-DR-PECy7 (isotype IgG2a, clone L243), anti-CD45-APCCy7 (isotype IgG1, clone 2D1) and anti-CD63-FITC (isotype IgG1, clone H5C6) were purchased from Becton Dickinson Pharmingen USA. All reagents were prepared using sterile disposable plastic tubes and pipette tips (BD Falcon, NJ, USA).
###end p 18
###begin title 19
Dilution and succussion procedures
###end title 19
###begin p 20
###xml 343 345 343 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 829 831 823 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 941 944 935 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;20</sup>
###xml 998 1001 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;32</sup>
Dilutions were made up in 15 ml sterile polystyrene conical tubes provided with caps; the serial dilutions were prepared with an actual histamine concentration four times greater than the intended final concentration, because the protocol subsequently called for a further fourfold dilution in the cell incubation mixture (see below). A 4 x 10-2 mol/l histamine solution (designated 1C) was made by diluting 500 mul of histamine stock in 4,500 mul of ultrapure water. From that preparation, a series of incremental 1/100 dilutions were prepared by diluting 50 mul of the preceding solution in 4,950 mul of ultrapure water and shaking by vigorous mechanical shaking (7.5 s at 20 strokes/s, vertical amplitude 7 +/- 2 mm) using an instrument from MGA Technologies, Lyon, France. The chosen working dilutions/succussions were 2C (10-4 mol/l histamine in the final sample assay) as a positive control, and seven ultra high dilutions from 10C (10-20 mol/l histamine in the final sample assay) to 16C (10-32 mol/l histamine in the final sample assay). Experiments with high water dilutions were performed using control test samples made up by an identical procedure, with the only difference that the stock starting solution was pure water rather than histamine. The histamine and water control dilutions/succussions were prepared fresh each day just before the experiments, and stored at room temperature and protected from light until use.
###end p 20
###begin title 21
Cell preparation
###end title 21
###begin p 22
###xml 117 118 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 958 959 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1146 1147 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1300 1301 1282 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1571 1573 1553 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1884 1886 1860 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 2032 2034 2008 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
Basophil-enriched cell samples were prepared by pooling the leukocyte buffy coats drawn from 3-ml venous samples of K2-ethylendiaminotetraacetic acid (EDTA) anti-coagulated peripheral blood of four healthy, non-allergic, subjects (blood donors). Blood from four different donors was employed in each separate experiment. All subjects were informed, by physicians of the Hospital Transfusion Service, about the use of their blood samples for research purposes; they completed and signed a specific consenting form for taking the samples and data processing. Venous blood samples were processed within 2-3 h of being drawn, using a differential centrifugation step procedure. The blood was diluted to 1:4 in refrigerated (+2degreesC/+ 8degreesC) HEPES modified buffer ([4-(2-hydroxyethylpiperazine-1-ethanesulonic acid] 20 mmol/l; NaCl 127 mmol/l; KCl 5 mmol/l; sodium-heparin 5 UI/ml, pH 7.4) using 14-ml polypropylene round-bottom tubes, and pelleted at 700 g for 15 min in a (+4degreesC) centrifuge. Leukocyte-rich buffy-coat layers were individually collected, suspended in the cold HEPES-heparin (HBE) buffered solution and centrifuged at 400 g for 10 min. Pelleted buffy-coats were washed out from supernatants, collected in a single tube, suspended in the cold HBE medium and centrifuged at 400 g for a further 10 min. Finally, the cells were suspended in the refrigerated HBE buffer at 1:4 v/v relative to starting whole blood volume. An aliquot of about 1 ml of the above HBE-suspended cell culture was transferred to a Bayer ADVIA 2120 automated hematocytometer [31] for basophil counting and yield evaluation. Pooled buffy coats having a mean count of 8.47 +/- 2.09 SD WBCx103/mul and an estimated basophil concentration of 92.25 +/- 18.43 SD cells/mul, were obtained. This yield corresponded to an enrichment of approximately 2.4 times relative to the starting whole blood [26]. Cells were treated with apyrogenic solutions and using sterile disposable plastic ware, and kept on ice to prevent any spontaneous activation [30]. Just before use, the cell suspension was pre-warmed for 10 min at 37degreesC and gently mixed.
###end p 22
###begin title 23
Cell treatment and activation
###end title 23
###begin p 24
###xml 461 462 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 473 474 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1003 1004 972 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1498 1500 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
A volume of 50 mul of the histamine or water dilutions was added to 5-ml round bottomed polypropylene vials containing 50 mul of 2 x concentrated HBE buffer (test tubes series "A") and warmed at 37degreesC for 10 min. Then 100 mul of the cell suspensions was added to each vial and incubated for 10 min at 37degreesC. A parallel series of 5 ml-round bottomed polystyrene vials were prepared, each containing 50 mul of an HBE solution supplemented with 5 mM CaCl2, 1 mM MgCl2 and with the anti-IgE agonist, where indicated (final concentration 1 mug/ml) (test tubes series "B"). After the 10-min incubation with histamine dilutions, 50 mul of the cell suspensions from test tube series "A" was added into those of series "B", previously brought to 37degreesC. Incubation with and without anti-IgE was carried out at 37degreesC for 30 min; the tubes were gently stirred every 10 min to allow proper mixing. The incubation was halted by adding 100 mul of ice-cold HBE buffer supplemented with 2.8 mmol/l Na3-EDTA, and the samples put on ice until staining with monoclonal antibodies. We only included experiments that met the following criteria: (a) significant cell activation following anti-IgE treatment, expressed as a statistically significant increase of 203c MFI in triplicate samples of anti-IgE treated cells as compared with triplicate samples of untreated, resting cells and, (b) inhibition induced by histamine 2C > 50% as compared with cell samples activated in the absence of histamine [17]. Applying these criteria, five of the seven experiments performed with histamine dilutions and five of the six experiments performed with water dilutions were selected as valid.
###end p 24
###begin title 25
Staining with monoclonal antibodies and sample analysis
###end title 25
###begin p 26
###xml 476 477 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 497 498 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 512 513 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 602 603 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 923 926 907 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dim</sup>
###xml 1024 1038 1008 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">non-expressing</sup>
###xml 1044 1050 1028 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 1091 1093 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1095 1097 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 1126 1140 1110 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">non-expressing</sup>
###xml 1149 1159 1133 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">expressing</sup>
Staining was performed at 4degreesC for 20 min with 10 mul/200 mul cell suspensions of the marker antibodies Anti-CD203c-PE, anti-CD123-PECy5, anti-CD63-FITC and with 5 mul/200 mul cell suspensions of the marker antibodies CD45-APCCy7 and HLA-DR-PECy7. The negative controls consisted of isotype matched, directly conjugated non-specific antibodies. Soon after staining, samples underwent erythrocyte lysis with 3 ml of a +4degreesC refrigerated ammonium-chloride solution (NH4Cl 155 mmol/l; NaHCO3 10 mmol/l, Na3EDTA 0.10 mmol/l, pH = 7.2) for 2 min on ice, after which the cells were pelleted at 500 g for 5 min in a refrigerated centrifuge. Supernatants were removed and the pellets gently suspended in 0.5 ml of a BD-Isoflow phoshpate saline (PBS, pH = 7.4) balanced buffer. Flow analysis was performed using a 488-633 nm two-laser flow cytometer (BD FACScanto). A region of low side-scatter cells was gated in the CD45dim lymphocyte area; in this region about 500 (450-550) cellular events from each sample with a HLADRnon-expressing/CD123bright phenotype were identified as basophils [26, 32]. The threshold between CD63non-expressing and CD63expressing basophils was arbitrarily set in each experiment close to the right-hand limit of the fluorescence peak of a sample of unstimulated, untreated cells. The MFI was calculated by the cytometer software by averaging the total fluorescence of the marker in the basophil gate.
###end p 26
###begin title 27
Statistics
###end title 27
###begin p 28
The observed MFI values for each experiment were recorded, and exploratory statistics such as the average and standard deviation were computed. Normality was checked by the Shapiro-Wilk test. The symmetry of the data was also tested, showing our experimental MFI values to be strongly right-skewed. In light of the non-symmetrical distribution of the data, which clearly did not satisfy the assumption of normality, it was decided to use non-parametric tests. Since ANOVA was unsuitable due to non-normality, for the global analysis of all the treatments, we adopted the Friedman non-parametric test for multiple-related samples. For the comparison between control and treatment groups, we applied the two-tailed Wilcoxon non-parametric test for paired samples. The data were first of all paired by experiment: since we had three different results within each experiment, we compared the lower, the middle and the upper value of the control group with the corresponding value of the treated group. We then took all the 15 values from the five experiments on each treatment group and compared them with all the 15 values from the control (no histamine) group. Since the CD203c is constitutively expressed at low level in resting, unstimulated basophils, the net activation response to anti-IgE (dMFI) was calculated by subtracting the mean resting fluorescence expressed by unstimulated cells in each experiment from the fluorescence values of anti-IgE activated samples. Then, the percentage inhibitory effect of each dilution on the cell activation to the anti-IgE was calculated, for each experiment, according to the formula:
###end p 28
###begin p 29
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The level of significance was set at P < 0.05.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 200 221 200 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="CR2" ref-type="bibr">Materials and methods</xref>
###xml 285 291 285 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 619 620 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 694 695 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 898 899 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1003 1004 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1121 1127 1120 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 1315 1317 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 1319 1321 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1375 1377 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1379 1385 1378 1384 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1448 1449 1447 1448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1498 1501 1497 1500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dim</sup>
###xml 1573 1587 1572 1586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">non-expressing</sup>
###xml 1593 1599 1592 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 1655 1657 1654 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q1</italic>
###xml 1690 1692 1689 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q2</italic>
###xml 1711 1713 1710 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q3</italic>
###xml 1716 1725 1715 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dot plots</italic>
###xml 1725 1726 1724 1725 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1731 1732 1730 1731 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1853 1867 1852 1866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low expressing</sup>
###xml 1872 1880 1871 1879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">negative</sup>
###xml 1888 1894 1887 1893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">area C</italic>
###xml 1898 1899 1897 1898 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1938 1939 1937 1938 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1993 1999 1992 1998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">area B</italic>
###xml 2003 2004 2002 2003 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1385 2005 1384 2004 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Human basophil gating with the BD-FACScanto flow cytometer. In <bold>a</bold> leukocytes are immunologically gated in the CD45<sup>dim</sup>-lymphocyte area and electronically captured as cellular events in HLADR<sup>non-expressing</sup>/CD123<sup>bright</sup> two-parameter plot to distinguish them from monocytes (<italic>Q1</italic>), plasmacytoid dendritic cells (<italic>Q2</italic>) and lymphocytes (<italic>Q3</italic>). <italic>Dot plots</italic><bold>b</bold> and <bold>c</bold> show CD63/CD203c expression in resting and anti-IgE-activated human basophils, respectively. The cloud of resting CD203c<sup>low expressing</sup>/CD63<sup>negative</sup> cells (<italic>area C</italic> in <bold>b</bold>) shifts to the right upon activation (<bold>c</bold>), but only a small percentage of cells express CD63 (<italic>area B</italic> in <bold>c</bold>)</p>
###xml 1385 2005 1384 2004 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">Human basophil gating with the BD-FACScanto flow cytometer. In <bold>a</bold> leukocytes are immunologically gated in the CD45<sup>dim</sup>-lymphocyte area and electronically captured as cellular events in HLADR<sup>non-expressing</sup>/CD123<sup>bright</sup> two-parameter plot to distinguish them from monocytes (<italic>Q1</italic>), plasmacytoid dendritic cells (<italic>Q2</italic>) and lymphocytes (<italic>Q3</italic>). <italic>Dot plots</italic><bold>b</bold> and <bold>c</bold> show CD63/CD203c expression in resting and anti-IgE-activated human basophils, respectively. The cloud of resting CD203c<sup>low expressing</sup>/CD63<sup>negative</sup> cells (<italic>area C</italic> in <bold>b</bold>) shifts to the right upon activation (<bold>c</bold>), but only a small percentage of cells express CD63 (<italic>area B</italic> in <bold>c</bold>)</p></caption>
###xml 2005 2005 2004 2004 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11_2009_44_Fig1_HTML" id="MO2"/>
###xml 1379 2005 1378 2004 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="32">Human basophil gating with the BD-FACScanto flow cytometer. In <bold>a</bold> leukocytes are immunologically gated in the CD45<sup>dim</sup>-lymphocyte area and electronically captured as cellular events in HLADR<sup>non-expressing</sup>/CD123<sup>bright</sup> two-parameter plot to distinguish them from monocytes (<italic>Q1</italic>), plasmacytoid dendritic cells (<italic>Q2</italic>) and lymphocytes (<italic>Q3</italic>). <italic>Dot plots</italic><bold>b</bold> and <bold>c</bold> show CD63/CD203c expression in resting and anti-IgE-activated human basophils, respectively. The cloud of resting CD203c<sup>low expressing</sup>/CD63<sup>negative</sup> cells (<italic>area C</italic> in <bold>b</bold>) shifts to the right upon activation (<bold>c</bold>), but only a small percentage of cells express CD63 (<italic>area B</italic> in <bold>c</bold>)</p></caption><graphic position="anchor" xlink:href="11_2009_44_Fig1_HTML" id="MO2"/></fig>
###xml 1795 1800 <span type="species:ncbi:9606">human</span>
Figure 1 shows a typical dot plot of basophil immunologic phenotyping and electronic capture. The HLADR-PECy7/CD123-PECy5 plot, constructed using the CD45-dim cells in the lymphocyte area (see Sect. "Materials and methods"), made it possible to define a clearly delimited area of CD123bright cells not expressing HLADR, which can be identified as basophils (Fig. 1a). Basophil response toward the agonist was initially examined by evaluating two-parameter dot plots of the acquired events (Fig. 1b, c). Non-activated (resting) basophils (Fig. 1b, panel C) typically showed a very low CD63 fluorescence (MFI from 0 to 103 units) and a low level of CD203c fluorescence (MFI from 3 x 102 to 3 x 103 units). Following 30 min of incubation with 1 mug/ml anti-IgE, only a small fraction of cells (from 3 to 15% of total basophils in the entire series of experiments) showed a CD63 bright phenotype (Fig. 1c, panels A and B), while between 60 and 80% of basophils up-regulated CD203c membrane expression (Fig. 1c, panels C and D). From these two-parameter dot plots, a large population of activated basophils expressing a CD203cbright phenotype was clearly evident, while most of these activated cells were negative at the CD63 staining. This confirms that CD203c is a more suitable type of marker for this type of study [17, 28], particularly when the extent of activation is low [26].Fig. 1Human basophil gating with the BD-FACScanto flow cytometer. In a leukocytes are immunologically gated in the CD45dim-lymphocyte area and electronically captured as cellular events in HLADRnon-expressing/CD123bright two-parameter plot to distinguish them from monocytes (Q1), plasmacytoid dendritic cells (Q2) and lymphocytes (Q3). Dot plotsb and c show CD63/CD203c expression in resting and anti-IgE-activated human basophils, respectively. The cloud of resting CD203clow expressing/CD63negative cells (area C in b) shifts to the right upon activation (c), but only a small percentage of cells express CD63 (area B in c)
###end p 31
###begin p 32
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dim</sup>
###xml 188 202 188 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">non-expressing</sup>
###xml 208 214 208 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 270 272 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q1</italic>
###xml 305 307 305 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q2</italic>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q3</italic>
###xml 331 340 331 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dot plots</italic>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 346 347 346 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 468 482 468 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low expressing</sup>
###xml 487 495 487 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">negative</sup>
###xml 503 509 503 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">area C</italic>
###xml 513 514 513 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">area B</italic>
###xml 618 619 618 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
Human basophil gating with the BD-FACScanto flow cytometer. In a leukocytes are immunologically gated in the CD45dim-lymphocyte area and electronically captured as cellular events in HLADRnon-expressing/CD123bright two-parameter plot to distinguish them from monocytes (Q1), plasmacytoid dendritic cells (Q2) and lymphocytes (Q3). Dot plotsb and c show CD63/CD203c expression in resting and anti-IgE-activated human basophils, respectively. The cloud of resting CD203clow expressing/CD63negative cells (area C in b) shifts to the right upon activation (c), but only a small percentage of cells express CD63 (area B in c)
###end p 32
###begin p 33
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 600 601 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 848 849 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1088 1089 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1105 1106 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1122 1123 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1139 1140 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1240 1241 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1251 1258 1251 1258 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1258 1378 1258 1378 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">CD203c expression in human basophils after the specified treatments, measured as mean fluorescence intensity units (MFI)</p>
###xml 1258 1378 1258 1378 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">CD203c expression in human basophils after the specified treatments, measured as mean fluorescence intensity units (MFI)</p></caption>
###xml 1378 1378 1378 1378 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 1378 1389 1378 1389 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No anti-IgE</th>
###xml 1389 1398 1389 1398 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1398 1407 1398 1407 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1407 1416 1407 1416 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1416 1425 1416 1425 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1425 1434 1425 1434 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1434 1443 1434 1443 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1443 1452 1443 1452 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1452 1461 1452 1461 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1461 1470 1461 1470 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1378 1470 1378 1470 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr>
###xml 1470 1494 1470 1494 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 1494 1518 1494 1518 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 1518 1549 1518 1549 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine positive control (2C)</th>
###xml 1549 1562 1549 1562 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 10C</th>
###xml 1562 1575 1562 1575 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 11C</th>
###xml 1575 1588 1575 1588 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 12C</th>
###xml 1588 1601 1588 1601 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 13C</th>
###xml 1601 1614 1601 1614 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 14C</th>
###xml 1614 1627 1614 1627 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 15C</th>
###xml 1627 1640 1627 1640 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 16C</th>
###xml 1470 1640 1470 1640 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr>
###xml 1378 1640 1378 1640 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead>
###xml 1663 1664 1663 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1640 1670 1640 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td>
###xml 1640 1670 1640 1670 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr>
###xml 1670 1674 1670 1674 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean</td>
###xml 1674 1680 1674 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1812.4</td>
###xml 1680 1686 1680 1686 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4389.0</td>
###xml 1686 1692 1686 1692 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2781.7</td>
###xml 1692 1698 1692 1698 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3936.9</td>
###xml 1698 1704 1698 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4248.3</td>
###xml 1704 1710 1704 1710 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4163.5</td>
###xml 1710 1716 1710 1716 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3858.7</td>
###xml 1716 1722 1716 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3818.7</td>
###xml 1722 1728 1722 1728 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4000.7</td>
###xml 1728 1734 1728 1734 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3899.9</td>
###xml 1670 1734 1670 1734 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean</td><td char="." align="char">1812.4</td><td char="." align="char">4389.0</td><td char="." align="char">2781.7</td><td char="." align="char">3936.9</td><td char="." align="char">4248.3</td><td char="." align="char">4163.5</td><td char="." align="char">3858.7</td><td char="." align="char">3818.7</td><td char="." align="char">4000.7</td><td char="." align="char">3899.9</td></tr>
###xml 1734 1736 1734 1736 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SD</td>
###xml 1736 1741 1736 1741 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">541.5</td>
###xml 1741 1747 1741 1747 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2052.9</td>
###xml 1747 1752 1747 1752 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">895.3</td>
###xml 1752 1758 1752 1758 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1353.3</td>
###xml 1758 1764 1758 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1819.3</td>
###xml 1764 1770 1764 1770 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1911.8</td>
###xml 1770 1776 1770 1776 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1469.4</td>
###xml 1776 1782 1776 1782 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1757.5</td>
###xml 1782 1788 1782 1788 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1597.5</td>
###xml 1788 1794 1788 1794 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1660.9</td>
###xml 1734 1794 1734 1794 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">SD</td><td char="." align="char">541.5</td><td char="." align="char">2052.9</td><td char="." align="char">895.3</td><td char="." align="char">1353.3</td><td char="." align="char">1819.3</td><td char="." align="char">1911.8</td><td char="." align="char">1469.4</td><td char="." align="char">1757.5</td><td char="." align="char">1597.5</td><td char="." align="char">1660.9</td></tr>
###xml 1794 1795 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1795 1796 1795 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1794 1796 1794 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>a</sup><italic>P</italic></td>
###xml 1796 1796 1796 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1796 1796 1796 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1796 1801 1796 1801 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 1801 1806 1801 1806 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.125</td>
###xml 1806 1811 1806 1811 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.776</td>
###xml 1811 1816 1811 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.047</td>
###xml 1816 1821 1816 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.061</td>
###xml 1821 1826 1821 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.003</td>
###xml 1826 1831 1826 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.036</td>
###xml 1831 1836 1831 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.009</td>
###xml 1794 1836 1794 1836 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.125</td><td char="." align="char">0.776</td><td char="." align="char">0.047</td><td char="." align="char">0.061</td><td char="." align="char">0.003</td><td char="." align="char">0.036</td><td char="." align="char">0.009</td></tr>
###xml 1836 1837 1836 1837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1837 1838 1837 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1836 1838 1836 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>b</sup><italic>P</italic></td>
###xml 1838 1838 1838 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1838 1838 1838 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1838 1839 1838 1839 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1839 1844 1839 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" colspan="7">0.012</td>
###xml 1836 1844 1836 1844 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.012</td></tr>
###xml 1640 1844 1640 1844 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1812.4</td><td char="." align="char">4389.0</td><td char="." align="char">2781.7</td><td char="." align="char">3936.9</td><td char="." align="char">4248.3</td><td char="." align="char">4163.5</td><td char="." align="char">3858.7</td><td char="." align="char">3818.7</td><td char="." align="char">4000.7</td><td char="." align="char">3899.9</td></tr><tr><td align="left">SD</td><td char="." align="char">541.5</td><td char="." align="char">2052.9</td><td char="." align="char">895.3</td><td char="." align="char">1353.3</td><td char="." align="char">1819.3</td><td char="." align="char">1911.8</td><td char="." align="char">1469.4</td><td char="." align="char">1757.5</td><td char="." align="char">1597.5</td><td char="." align="char">1660.9</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.125</td><td char="." align="char">0.776</td><td char="." align="char">0.047</td><td char="." align="char">0.061</td><td char="." align="char">0.003</td><td char="." align="char">0.036</td><td char="." align="char">0.009</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.012</td></tr></tbody>
###xml 1378 1844 1378 1844 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1812.4</td><td char="." align="char">4389.0</td><td char="." align="char">2781.7</td><td char="." align="char">3936.9</td><td char="." align="char">4248.3</td><td char="." align="char">4163.5</td><td char="." align="char">3858.7</td><td char="." align="char">3818.7</td><td char="." align="char">4000.7</td><td char="." align="char">3899.9</td></tr><tr><td align="left">SD</td><td char="." align="char">541.5</td><td char="." align="char">2052.9</td><td char="." align="char">895.3</td><td char="." align="char">1353.3</td><td char="." align="char">1819.3</td><td char="." align="char">1911.8</td><td char="." align="char">1469.4</td><td char="." align="char">1757.5</td><td char="." align="char">1597.5</td><td char="." align="char">1660.9</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.125</td><td char="." align="char">0.776</td><td char="." align="char">0.047</td><td char="." align="char">0.061</td><td char="." align="char">0.003</td><td char="." align="char">0.036</td><td char="." align="char">0.009</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.012</td></tr></tbody></table>
###xml 1844 1844 1844 1844 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1844 1855 1844 1855 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No anti-IgE</th>
###xml 1855 1864 1855 1864 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1864 1873 1864 1873 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1873 1882 1873 1882 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1882 1891 1882 1891 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1891 1900 1891 1900 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1900 1909 1900 1909 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1909 1918 1909 1918 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1918 1927 1918 1927 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1927 1936 1927 1936 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1844 1936 1844 1936 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr>
###xml 1936 1936 1936 1936 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1936 1960 1936 1960 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 1960 1984 1960 1984 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 1984 2015 1984 2015 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine positive control (2C)</th>
###xml 2015 2024 2015 2024 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 10C</th>
###xml 2024 2033 2024 2033 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 11C</th>
###xml 2033 2042 2033 2042 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 12C</th>
###xml 2042 2051 2042 2051 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 13C</th>
###xml 2051 2060 2051 2060 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 14C</th>
###xml 2060 2069 2060 2069 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 15C</th>
###xml 2069 2078 2069 2078 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 16C</th>
###xml 1936 2078 1936 2078 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr>
###xml 1844 2078 1844 2078 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left"/><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead>
###xml 2097 2098 2097 2098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2078 2104 2078 2104 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td>
###xml 2078 2104 2078 2104 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr>
###xml 2104 2108 2104 2108 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean</td>
###xml 2108 2114 2108 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1552.2</td>
###xml 2114 2120 2114 2120 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5694.3</td>
###xml 2120 2126 2120 2126 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3252.9</td>
###xml 2126 2132 2126 2132 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5667.9</td>
###xml 2132 2138 2132 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5696.2</td>
###xml 2138 2144 2138 2144 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5927.6</td>
###xml 2144 2150 2144 2150 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5606.4</td>
###xml 2150 2156 2150 2156 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5760.7</td>
###xml 2156 2162 2156 2162 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5625.4</td>
###xml 2162 2168 2162 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5850.9</td>
###xml 2104 2168 2104 2168 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean</td><td char="." align="char">1552.2</td><td char="." align="char">5694.3</td><td char="." align="char">3252.9</td><td char="." align="char">5667.9</td><td char="." align="char">5696.2</td><td char="." align="char">5927.6</td><td char="." align="char">5606.4</td><td char="." align="char">5760.7</td><td char="." align="char">5625.4</td><td char="." align="char">5850.9</td></tr>
###xml 2168 2170 2168 2170 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SD</td>
###xml 2170 2175 2170 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">372.3</td>
###xml 2175 2181 2175 2181 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1391.5</td>
###xml 2181 2186 2181 2186 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">647.4</td>
###xml 2186 2192 2186 2192 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1762.4</td>
###xml 2192 2198 2192 2198 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1970.9</td>
###xml 2198 2204 2198 2204 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1610.0</td>
###xml 2204 2210 2204 2210 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1882.2</td>
###xml 2210 2216 2210 2216 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1678.7</td>
###xml 2216 2222 2216 2222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1537.7</td>
###xml 2222 2228 2222 2228 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2204.6</td>
###xml 2168 2228 2168 2228 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">SD</td><td char="." align="char">372.3</td><td char="." align="char">1391.5</td><td char="." align="char">647.4</td><td char="." align="char">1762.4</td><td char="." align="char">1970.9</td><td char="." align="char">1610.0</td><td char="." align="char">1882.2</td><td char="." align="char">1678.7</td><td char="." align="char">1537.7</td><td char="." align="char">2204.6</td></tr>
###xml 2228 2229 2228 2229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2229 2230 2229 2230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2228 2230 2228 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>a</sup><italic>P</italic></td>
###xml 2230 2230 2230 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2230 2230 2230 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2230 2235 2230 2235 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 2235 2240 2235 2240 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.820</td>
###xml 2240 2245 2240 2245 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.977</td>
###xml 2245 2250 2245 2250 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.211</td>
###xml 2250 2255 2250 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.691</td>
###xml 2255 2260 2255 2260 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.733</td>
###xml 2260 2265 2260 2265 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.334</td>
###xml 2265 2270 2265 2270 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.910</td>
###xml 2228 2270 2228 2270 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.820</td><td char="." align="char">0.977</td><td char="." align="char">0.211</td><td char="." align="char">0.691</td><td char="." align="char">0.733</td><td char="." align="char">0.334</td><td char="." align="char">0.910</td></tr>
###xml 2270 2271 2270 2271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2271 2272 2271 2272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2270 2272 2270 2272 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>b</sup><italic>P</italic></td>
###xml 2272 2272 2272 2272 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2272 2272 2272 2272 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2272 2273 2272 2273 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 2273 2278 2273 2278 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" colspan="7">0.590</td>
###xml 2270 2278 2270 2278 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.590</td></tr>
###xml 2078 2278 2078 2278 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1552.2</td><td char="." align="char">5694.3</td><td char="." align="char">3252.9</td><td char="." align="char">5667.9</td><td char="." align="char">5696.2</td><td char="." align="char">5927.6</td><td char="." align="char">5606.4</td><td char="." align="char">5760.7</td><td char="." align="char">5625.4</td><td char="." align="char">5850.9</td></tr><tr><td align="left">SD</td><td char="." align="char">372.3</td><td char="." align="char">1391.5</td><td char="." align="char">647.4</td><td char="." align="char">1762.4</td><td char="." align="char">1970.9</td><td char="." align="char">1610.0</td><td char="." align="char">1882.2</td><td char="." align="char">1678.7</td><td char="." align="char">1537.7</td><td char="." align="char">2204.6</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.820</td><td char="." align="char">0.977</td><td char="." align="char">0.211</td><td char="." align="char">0.691</td><td char="." align="char">0.733</td><td char="." align="char">0.334</td><td char="." align="char">0.910</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.590</td></tr></tbody>
###xml 1844 2278 1844 2278 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left"/><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1552.2</td><td char="." align="char">5694.3</td><td char="." align="char">3252.9</td><td char="." align="char">5667.9</td><td char="." align="char">5696.2</td><td char="." align="char">5927.6</td><td char="." align="char">5606.4</td><td char="." align="char">5760.7</td><td char="." align="char">5625.4</td><td char="." align="char">5850.9</td></tr><tr><td align="left">SD</td><td char="." align="char">372.3</td><td char="." align="char">1391.5</td><td char="." align="char">647.4</td><td char="." align="char">1762.4</td><td char="." align="char">1970.9</td><td char="." align="char">1610.0</td><td char="." align="char">1882.2</td><td char="." align="char">1678.7</td><td char="." align="char">1537.7</td><td char="." align="char">2204.6</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.820</td><td char="." align="char">0.977</td><td char="." align="char">0.211</td><td char="." align="char">0.691</td><td char="." align="char">0.733</td><td char="." align="char">0.334</td><td char="." align="char">0.910</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.590</td></tr></tbody></table>
###xml 2278 2279 2278 2279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2279 2280 2279 2280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2278 2427 2278 2427 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p>
###xml 2427 2428 2427 2428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2428 2429 2428 2429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2427 2532 2427 2532 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p>
###xml 2278 2532 2278 2532 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p><p textid="36"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p></table-wrap-foot>
###xml 1251 2532 1251 2532 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="34">CD203c expression in human basophils after the specified treatments, measured as mean fluorescence intensity units (MFI)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1812.4</td><td char="." align="char">4389.0</td><td char="." align="char">2781.7</td><td char="." align="char">3936.9</td><td char="." align="char">4248.3</td><td char="." align="char">4163.5</td><td char="." align="char">3858.7</td><td char="." align="char">3818.7</td><td char="." align="char">4000.7</td><td char="." align="char">3899.9</td></tr><tr><td align="left">SD</td><td char="." align="char">541.5</td><td char="." align="char">2052.9</td><td char="." align="char">895.3</td><td char="." align="char">1353.3</td><td char="." align="char">1819.3</td><td char="." align="char">1911.8</td><td char="." align="char">1469.4</td><td char="." align="char">1757.5</td><td char="." align="char">1597.5</td><td char="." align="char">1660.9</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.125</td><td char="." align="char">0.776</td><td char="." align="char">0.047</td><td char="." align="char">0.061</td><td char="." align="char">0.003</td><td char="." align="char">0.036</td><td char="." align="char">0.009</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.012</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left"/><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1552.2</td><td char="." align="char">5694.3</td><td char="." align="char">3252.9</td><td char="." align="char">5667.9</td><td char="." align="char">5696.2</td><td char="." align="char">5927.6</td><td char="." align="char">5606.4</td><td char="." align="char">5760.7</td><td char="." align="char">5625.4</td><td char="." align="char">5850.9</td></tr><tr><td align="left">SD</td><td char="." align="char">372.3</td><td char="." align="char">1391.5</td><td char="." align="char">647.4</td><td char="." align="char">1762.4</td><td char="." align="char">1970.9</td><td char="." align="char">1610.0</td><td char="." align="char">1882.2</td><td char="." align="char">1678.7</td><td char="." align="char">1537.7</td><td char="." align="char">2204.6</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.820</td><td char="." align="char">0.977</td><td char="." align="char">0.211</td><td char="." align="char">0.691</td><td char="." align="char">0.733</td><td char="." align="char">0.334</td><td char="." align="char">0.910</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.590</td></tr></tbody></table><table-wrap-foot><p textid="35"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p><p textid="36"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p></table-wrap-foot></table-wrap>
###xml 1279 1284 <span type="species:ncbi:9606">human</span>
Table 1 reports the data of five experiments, each one done in triplicate, where basophil samples were activated in the absence and in the presence of histamine at increasing dilutions. Activation of basophils with anti-IgE caused a considerable increase in the MFI of CD203c compared with unstimulated cells (from a mean of 1812.4 units to a mean of 4389.0 units in the series of five experiments). The complete series of 15 replicates was analyzed using non-parametric tests since the distribution of values was not normal. Histamine 2C (positive control) reduced the response to 2781.7 MFI units (P = 0.001). A global analysis using the Friedman test for multiple samples indicated that the differences between control samples (no histamine) and the series of samples treated with the high dilutions of histamine were statistically significant (P = 0.012), even excluding the 2C test solution which was the obvious positive control in this series. The two-sample comparison with control revealed significant inhibitions of CD203c up-regulation following incubation with histamine 12C (P = 0.047), 14C (P = 0.003), 15C (P = 0.036), 16C (P = 0.009); with histamine 13C the difference was not significant but very close to the limit value (P = 0.061).Table 1CD203c expression in human basophils after the specified treatments, measured as mean fluorescence intensity units (MFI)No anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgEUntreated (no histamine)Untreated (no histamine)Histamine positive control (2C)Histamine 10CHistamine 11CHistamine 12CHistamine 13CHistamine 14CHistamine 15CHistamine 16CHistamine experiments (n = 15)Mean1812.44389.02781.73936.94248.34163.53858.73818.74000.73899.9SD541.52052.9895.31353.31819.31911.81469.41757.51597.51660.9aP0.0010.1250.7760.0470.0610.0030.0360.009bP-0.012No anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgEUntreated (no histamine)Untreated (no histamine)Histamine positive control (2C)Water 10CWater 11CWater 12CWater 13CWater 14CWater 15CWater 16CWater experiments (n = 15)Mean1552.25694.33252.95667.95696.25927.65606.45760.75625.45850.9SD372.31391.5647.41762.41970.91610.01882.21678.71537.72204.6aP0.0010.8200.9770.2110.6910.7330.3340.910bP-0.590aP Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental seriesbP Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)
###end p 33
###begin p 34
###xml 21 26 <span type="species:ncbi:9606">human</span>
CD203c expression in human basophils after the specified treatments, measured as mean fluorescence intensity units (MFI)
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
aP Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
bP Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)
###end p 36
###begin p 37
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1178 1179 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Table 1 shows the results of five separate experiments in which succussed high dilutions of histamine were replaced with succussed high dilutions of water. For technical reasons due to the high number of tested dilutions and of replicates and in order to maintain high analytical accuracy, we could not test all histamine dilutions and all water dilutions in the same cells, so the two series of experiments reported in Table 1 were done in separate sequences, but using exactly the same protocol and the same water batch. The response of control, uninhibited samples to anti-IgE shifted from a mean of 1552.2 units to a mean of 5694.3 units and histamine 2C dilution (positive control for inhibition) reduced CD203c expression to 3252.9 MFI units (P = 0.001), showing that the cells were fully sensitive to histamine, as well as the first series reported in Table 1. However, none of the water succussed dilutions showed any significant effect on the test system in two-sample comparisons with uninhibited, anti-IgE-activated sample. The Friedman test for the control and high dilutions, with the histamine 2C sample (positive control) omitted from the analysis, was negative (P = 0.590).
###end p 37
###begin p 38
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 36 46 36 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">expressing</sup>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 444 454 444 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">expressing</sup>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1344 1354 1344 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">expressing</sup>
###xml 1377 1378 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1400 1401 1400 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1404 1405 1404 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1508 1518 1508 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">expressing</sup>
###xml 1745 1752 1745 1752 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1752 1874 1752 1874 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">CD63 expression in human basophils after the specified treatments, measured as percentage of cells which up-regulated CD63</p>
###xml 1752 1874 1752 1874 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">CD63 expression in human basophils after the specified treatments, measured as percentage of cells which up-regulated CD63</p></caption>
###xml 1874 1874 1874 1874 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 1874 1885 1874 1885 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No anti-IgE</th>
###xml 1885 1894 1885 1894 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1894 1903 1894 1903 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1903 1912 1903 1912 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1912 1921 1912 1921 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1921 1930 1921 1930 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1930 1939 1930 1939 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1939 1948 1939 1948 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1948 1957 1948 1957 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1957 1966 1957 1966 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 1874 1966 1874 1966 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr>
###xml 1966 1990 1966 1990 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 1990 2014 1990 2014 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 2014 2045 2014 2045 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine positive control (2C)</th>
###xml 2045 2058 2045 2058 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 10C</th>
###xml 2058 2071 2058 2071 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 11C</th>
###xml 2071 2084 2071 2084 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 12C</th>
###xml 2084 2097 2084 2097 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 13C</th>
###xml 2097 2110 2097 2110 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 14C</th>
###xml 2110 2123 2110 2123 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 15C</th>
###xml 2123 2136 2123 2136 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine 16C</th>
###xml 1966 2136 1966 2136 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr>
###xml 1874 2136 1874 2136 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead>
###xml 2159 2160 2159 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2136 2166 2136 2166 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td>
###xml 2136 2166 2136 2166 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr>
###xml 2166 2170 2166 2170 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean</td>
###xml 2170 2174 2170 2174 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.07</td>
###xml 2174 2178 2174 2178 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.22</td>
###xml 2178 2182 2178 2182 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.20</td>
###xml 2182 2186 2182 2186 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.75</td>
###xml 2186 2190 2186 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.62</td>
###xml 2190 2194 2190 2194 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.64</td>
###xml 2194 2198 2194 2198 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.54</td>
###xml 2198 2202 2198 2202 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.25</td>
###xml 2202 2206 2202 2206 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.60</td>
###xml 2206 2210 2206 2210 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.11</td>
###xml 2166 2210 2166 2210 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean</td><td char="." align="char">1.07</td><td char="." align="char">8.22</td><td char="." align="char">4.20</td><td char="." align="char">7.75</td><td char="." align="char">8.62</td><td char="." align="char">8.64</td><td char="." align="char">7.54</td><td char="." align="char">7.25</td><td char="." align="char">7.60</td><td char="." align="char">7.11</td></tr>
###xml 2210 2212 2210 2212 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SD</td>
###xml 2212 2216 2212 2216 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.65</td>
###xml 2216 2220 2216 2220 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.53</td>
###xml 2220 2224 2220 2224 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.69</td>
###xml 2224 2228 2224 2228 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.44</td>
###xml 2228 2233 2228 2233 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10.39</td>
###xml 2233 2237 2233 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.88</td>
###xml 2237 2241 2237 2241 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.45</td>
###xml 2241 2245 2241 2245 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.70</td>
###xml 2245 2249 2245 2249 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.55</td>
###xml 2249 2253 2249 2253 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.37</td>
###xml 2210 2253 2210 2253 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">SD</td><td char="." align="char">0.65</td><td char="." align="char">9.53</td><td char="." align="char">3.69</td><td char="." align="char">9.44</td><td char="." align="char">10.39</td><td char="." align="char">9.88</td><td char="." align="char">8.45</td><td char="." align="char">8.70</td><td char="." align="char">7.55</td><td char="." align="char">7.37</td></tr>
###xml 2253 2254 2253 2254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2254 2255 2254 2255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2253 2255 2253 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>a</sup><italic>P</italic></td>
###xml 2255 2255 2255 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2255 2255 2255 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2255 2260 2255 2260 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.008</td>
###xml 2260 2265 2260 2265 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.222</td>
###xml 2265 2270 2265 2270 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.609</td>
###xml 2270 2275 2270 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.410</td>
###xml 2275 2280 2275 2280 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.132</td>
###xml 2280 2285 2280 2285 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.065</td>
###xml 2285 2290 2285 2290 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.278</td>
###xml 2290 2295 2290 2295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.222</td>
###xml 2253 2295 2253 2295 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.008</td><td char="." align="char">0.222</td><td char="." align="char">0.609</td><td char="." align="char">0.410</td><td char="." align="char">0.132</td><td char="." align="char">0.065</td><td char="." align="char">0.278</td><td char="." align="char">0.222</td></tr>
###xml 2295 2296 2295 2296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2296 2297 2296 2297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2295 2297 2295 2297 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>b</sup><italic>P</italic></td>
###xml 2297 2297 2297 2297 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2297 2297 2297 2297 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2297 2298 2297 2298 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 2298 2303 2298 2303 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" colspan="7">0.300</td>
###xml 2295 2303 2295 2303 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.300</td></tr>
###xml 2136 2303 2136 2303 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.07</td><td char="." align="char">8.22</td><td char="." align="char">4.20</td><td char="." align="char">7.75</td><td char="." align="char">8.62</td><td char="." align="char">8.64</td><td char="." align="char">7.54</td><td char="." align="char">7.25</td><td char="." align="char">7.60</td><td char="." align="char">7.11</td></tr><tr><td align="left">SD</td><td char="." align="char">0.65</td><td char="." align="char">9.53</td><td char="." align="char">3.69</td><td char="." align="char">9.44</td><td char="." align="char">10.39</td><td char="." align="char">9.88</td><td char="." align="char">8.45</td><td char="." align="char">8.70</td><td char="." align="char">7.55</td><td char="." align="char">7.37</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.008</td><td char="." align="char">0.222</td><td char="." align="char">0.609</td><td char="." align="char">0.410</td><td char="." align="char">0.132</td><td char="." align="char">0.065</td><td char="." align="char">0.278</td><td char="." align="char">0.222</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.300</td></tr></tbody>
###xml 1874 2303 1874 2303 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.07</td><td char="." align="char">8.22</td><td char="." align="char">4.20</td><td char="." align="char">7.75</td><td char="." align="char">8.62</td><td char="." align="char">8.64</td><td char="." align="char">7.54</td><td char="." align="char">7.25</td><td char="." align="char">7.60</td><td char="." align="char">7.11</td></tr><tr><td align="left">SD</td><td char="." align="char">0.65</td><td char="." align="char">9.53</td><td char="." align="char">3.69</td><td char="." align="char">9.44</td><td char="." align="char">10.39</td><td char="." align="char">9.88</td><td char="." align="char">8.45</td><td char="." align="char">8.70</td><td char="." align="char">7.55</td><td char="." align="char">7.37</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.008</td><td char="." align="char">0.222</td><td char="." align="char">0.609</td><td char="." align="char">0.410</td><td char="." align="char">0.132</td><td char="." align="char">0.065</td><td char="." align="char">0.278</td><td char="." align="char">0.222</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.300</td></tr></tbody></table>
###xml 2303 2303 2303 2303 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 2303 2314 2303 2314 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No anti-IgE</th>
###xml 2314 2323 2314 2323 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2323 2332 2323 2332 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2332 2341 2332 2341 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2341 2350 2341 2350 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2350 2359 2350 2359 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2359 2368 2359 2368 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2368 2377 2368 2377 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2377 2386 2377 2386 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2386 2395 2386 2395 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+Anti-IgE</th>
###xml 2303 2395 2303 2395 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr>
###xml 2395 2419 2395 2419 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 2419 2443 2419 2443 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Untreated (no histamine)</th>
###xml 2443 2474 2443 2474 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Histamine positive control (2C)</th>
###xml 2474 2483 2474 2483 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 10C</th>
###xml 2483 2492 2483 2492 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 11C</th>
###xml 2492 2501 2492 2501 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 12C</th>
###xml 2501 2510 2501 2510 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 13C</th>
###xml 2510 2519 2510 2519 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 14C</th>
###xml 2519 2528 2519 2528 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 15C</th>
###xml 2528 2537 2528 2537 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Water 16C</th>
###xml 2395 2537 2395 2537 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr>
###xml 2303 2537 2303 2537 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead>
###xml 2556 2557 2556 2557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2537 2563 2537 2563 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td>
###xml 2537 2563 2537 2563 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr>
###xml 2563 2567 2563 2567 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean</td>
###xml 2567 2571 2567 2571 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.81</td>
###xml 2571 2576 2571 2576 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.87</td>
###xml 2576 2580 2576 2580 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.31</td>
###xml 2580 2585 2580 2585 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.27</td>
###xml 2585 2590 2585 2590 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16.58</td>
###xml 2590 2595 2590 2595 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.10</td>
###xml 2595 2600 2595 2600 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.21</td>
###xml 2600 2605 2600 2605 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.65</td>
###xml 2605 2610 2605 2610 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14.94</td>
###xml 2610 2615 2610 2615 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.23</td>
###xml 2563 2615 2563 2615 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean</td><td char="." align="char">1.81</td><td char="." align="char">15.87</td><td char="." align="char">7.31</td><td char="." align="char">15.27</td><td char="." align="char">16.58</td><td char="." align="char">15.10</td><td char="." align="char">15.21</td><td char="." align="char">15.65</td><td char="." align="char">14.94</td><td char="." align="char">15.23</td></tr>
###xml 2615 2617 2615 2617 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SD</td>
###xml 2617 2621 2617 2621 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.35</td>
###xml 2621 2625 2621 2625 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.09</td>
###xml 2625 2629 2625 2629 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.75</td>
###xml 2629 2633 2629 2633 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.56</td>
###xml 2633 2637 2633 2637 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.30</td>
###xml 2637 2641 2637 2641 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.31</td>
###xml 2641 2645 2641 2645 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.14</td>
###xml 2645 2649 2645 2649 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.27</td>
###xml 2649 2653 2649 2653 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.91</td>
###xml 2653 2657 2653 2657 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.58</td>
###xml 2615 2657 2615 2657 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">SD</td><td char="." align="char">1.35</td><td char="." align="char">8.09</td><td char="." align="char">3.75</td><td char="." align="char">7.56</td><td char="." align="char">9.30</td><td char="." align="char">7.31</td><td char="." align="char">7.14</td><td char="." align="char">7.27</td><td char="." align="char">7.91</td><td char="." align="char">8.58</td></tr>
###xml 2657 2658 2657 2658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2658 2659 2658 2659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2657 2659 2657 2659 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>a</sup><italic>P</italic></td>
###xml 2659 2659 2659 2659 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2659 2659 2659 2659 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2659 2664 2659 2664 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 2664 2669 2664 2669 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.280</td>
###xml 2669 2674 2669 2674 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.293</td>
###xml 2674 2679 2674 2679 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.211</td>
###xml 2679 2684 2679 2684 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.191</td>
###xml 2684 2689 2684 2689 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.730</td>
###xml 2689 2694 2689 2694 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.140</td>
###xml 2694 2699 2694 2699 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.410</td>
###xml 2657 2699 2657 2699 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.280</td><td char="." align="char">0.293</td><td char="." align="char">0.211</td><td char="." align="char">0.191</td><td char="." align="char">0.730</td><td char="." align="char">0.140</td><td char="." align="char">0.410</td></tr>
###xml 2699 2700 2699 2700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2700 2701 2700 2701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2699 2701 2699 2701 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><sup>b</sup><italic>P</italic></td>
###xml 2701 2701 2701 2701 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2701 2701 2701 2701 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 2701 2702 2701 2702 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 2702 2707 2702 2707 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" colspan="7">0.520</td>
###xml 2699 2707 2699 2707 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.520</td></tr>
###xml 2537 2707 2537 2707 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.81</td><td char="." align="char">15.87</td><td char="." align="char">7.31</td><td char="." align="char">15.27</td><td char="." align="char">16.58</td><td char="." align="char">15.10</td><td char="." align="char">15.21</td><td char="." align="char">15.65</td><td char="." align="char">14.94</td><td char="." align="char">15.23</td></tr><tr><td align="left">SD</td><td char="." align="char">1.35</td><td char="." align="char">8.09</td><td char="." align="char">3.75</td><td char="." align="char">7.56</td><td char="." align="char">9.30</td><td char="." align="char">7.31</td><td char="." align="char">7.14</td><td char="." align="char">7.27</td><td char="." align="char">7.91</td><td char="." align="char">8.58</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.280</td><td char="." align="char">0.293</td><td char="." align="char">0.211</td><td char="." align="char">0.191</td><td char="." align="char">0.730</td><td char="." align="char">0.140</td><td char="." align="char">0.410</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.520</td></tr></tbody>
###xml 2303 2707 2303 2707 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.81</td><td char="." align="char">15.87</td><td char="." align="char">7.31</td><td char="." align="char">15.27</td><td char="." align="char">16.58</td><td char="." align="char">15.10</td><td char="." align="char">15.21</td><td char="." align="char">15.65</td><td char="." align="char">14.94</td><td char="." align="char">15.23</td></tr><tr><td align="left">SD</td><td char="." align="char">1.35</td><td char="." align="char">8.09</td><td char="." align="char">3.75</td><td char="." align="char">7.56</td><td char="." align="char">9.30</td><td char="." align="char">7.31</td><td char="." align="char">7.14</td><td char="." align="char">7.27</td><td char="." align="char">7.91</td><td char="." align="char">8.58</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.280</td><td char="." align="char">0.293</td><td char="." align="char">0.211</td><td char="." align="char">0.191</td><td char="." align="char">0.730</td><td char="." align="char">0.140</td><td char="." align="char">0.410</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.520</td></tr></tbody></table>
###xml 2707 2708 2707 2708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2708 2709 2708 2709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2707 2856 2707 2856 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p>
###xml 2856 2857 2856 2857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2857 2858 2857 2858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2856 2961 2856 2961 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p>
###xml 2707 2961 2707 2961 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p><p textid="41"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p></table-wrap-foot>
###xml 1745 2961 1745 2961 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="39">CD63 expression in human basophils after the specified treatments, measured as percentage of cells which up-regulated CD63</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Histamine 10C</th><th align="left">Histamine 11C</th><th align="left">Histamine 12C</th><th align="left">Histamine 13C</th><th align="left">Histamine 14C</th><th align="left">Histamine 15C</th><th align="left">Histamine 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Histamine experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.07</td><td char="." align="char">8.22</td><td char="." align="char">4.20</td><td char="." align="char">7.75</td><td char="." align="char">8.62</td><td char="." align="char">8.64</td><td char="." align="char">7.54</td><td char="." align="char">7.25</td><td char="." align="char">7.60</td><td char="." align="char">7.11</td></tr><tr><td align="left">SD</td><td char="." align="char">0.65</td><td char="." align="char">9.53</td><td char="." align="char">3.69</td><td char="." align="char">9.44</td><td char="." align="char">10.39</td><td char="." align="char">9.88</td><td char="." align="char">8.45</td><td char="." align="char">8.70</td><td char="." align="char">7.55</td><td char="." align="char">7.37</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.008</td><td char="." align="char">0.222</td><td char="." align="char">0.609</td><td char="." align="char">0.410</td><td char="." align="char">0.132</td><td char="." align="char">0.065</td><td char="." align="char">0.278</td><td char="." align="char">0.222</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.300</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">No anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th><th align="left">+Anti-IgE</th></tr><tr><th align="left">Untreated (no histamine)</th><th align="left">Untreated (no histamine)</th><th align="left">Histamine positive control (2C)</th><th align="left">Water 10C</th><th align="left">Water 11C</th><th align="left">Water 12C</th><th align="left">Water 13C</th><th align="left">Water 14C</th><th align="left">Water 15C</th><th align="left">Water 16C</th></tr></thead><tbody><tr><td align="left" colspan="11">Water experiments (<italic>n</italic>&#160;=&#160;15)</td></tr><tr><td align="left">Mean</td><td char="." align="char">1.81</td><td char="." align="char">15.87</td><td char="." align="char">7.31</td><td char="." align="char">15.27</td><td char="." align="char">16.58</td><td char="." align="char">15.10</td><td char="." align="char">15.21</td><td char="." align="char">15.65</td><td char="." align="char">14.94</td><td char="." align="char">15.23</td></tr><tr><td align="left">SD</td><td char="." align="char">1.35</td><td char="." align="char">8.09</td><td char="." align="char">3.75</td><td char="." align="char">7.56</td><td char="." align="char">9.30</td><td char="." align="char">7.31</td><td char="." align="char">7.14</td><td char="." align="char">7.27</td><td char="." align="char">7.91</td><td char="." align="char">8.58</td></tr><tr><td align="left"><sup>a</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">0.001</td><td char="." align="char">0.280</td><td char="." align="char">0.293</td><td char="." align="char">0.211</td><td char="." align="char">0.191</td><td char="." align="char">0.730</td><td char="." align="char">0.140</td><td char="." align="char">0.410</td></tr><tr><td align="left"><sup>b</sup><italic>P</italic></td><td char="." align="char"/><td char="." align="char"/><td char="." align="char">&#8211;</td><td char="." align="char" colspan="7">0.520</td></tr></tbody></table><table-wrap-foot><p textid="40"><sup>a</sup><italic>P</italic> Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series</p><p textid="41"><sup>b</sup><italic>P</italic> Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)</p></table-wrap-foot></table-wrap>
###xml 1771 1776 <span type="species:ncbi:9606">human</span>
Table 2 shows the percentage of CD63expressing cells. These data are from the same cell samples tested for CD203c MFI and reported in Table 1. The percentage of spontaneous activation (no anti-IgE) was very low (1.07-1.81% in histamine and water experiments, respectively), indicating that the isolation procedure yielded a basophil preparation at resting state and close to physiological conditions. Following challenge with anti-IgE, the CD63expressing cells increased to 8.22% in the series of experiments testing high histamine dilutions (2a), and to 15.87% in the series of experiments testing high water dilutions (2b). This difference between these two series of experiments, in the basophil response to anti-IgE could be explained by the very low expression of CD63 in our experimental conditions (see also Fig. 1), which is associated with high variability of data. A further factor of variability could be related to high inter-individual differences of basophil responsiveness, possibly due to seasonal variations or previous contacts with sensitizing substances, previously noted by others [27, 33], which may be reduced but not completely eliminated by pooling buffy-coats from different donors. Anymore, also with this marker all the cells tested were strongly inhibited by histamine at low dilution (2C), which decreased the CD63expressing cells to 4.20% (Table 2) and to 7.31% (Table 2) (P = 0.008 and 0.001, respectively). A few high histamine dilutions also decreased the percentage of CD63expressing cells (e.g. 13C, 14C, 15C, 16C), but because of high variation of values this effect was not statistically significant (borderline for histamine 14C). No effects were determined by highly diluted water and succussed solutions.Table 2CD63 expression in human basophils after the specified treatments, measured as percentage of cells which up-regulated CD63No anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgEUntreated (no histamine)Untreated (no histamine)Histamine positive control (2C)Histamine 10CHistamine 11CHistamine 12CHistamine 13CHistamine 14CHistamine 15CHistamine 16CHistamine experiments (n = 15)Mean1.078.224.207.758.628.647.547.257.607.11SD0.659.533.699.4410.399.888.458.707.557.37aP0.0080.2220.6090.4100.1320.0650.2780.222bP-0.300No anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgE+Anti-IgEUntreated (no histamine)Untreated (no histamine)Histamine positive control (2C)Water 10CWater 11CWater 12CWater 13CWater 14CWater 15CWater 16CWater experiments (n = 15)Mean1.8115.877.3115.2716.5815.1015.2115.6514.9415.23SD1.358.093.757.569.307.317.147.277.918.58aP0.0010.2800.2930.2110.1910.7300.1400.410bP-0.520aP Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental seriesbP Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)
###end p 38
###begin p 39
###xml 19 24 <span type="species:ncbi:9606">human</span>
CD63 expression in human basophils after the specified treatments, measured as percentage of cells which up-regulated CD63
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
aP Wilcoxon test of Histamine dilutions or Water dilutions versus Untreated (no histamine) anti-IgE-activated samples of the same experimental series
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
bP Friedman test of the series of anti-IgE-activated samples (omitting the 2C Histamine positive control)
###end p 41
###begin p 42
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 892 898 892 898 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1018 1019 1018 1019 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1051 1052 1051 1052 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1106 1107 1104 1105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1139 1140 1137 1138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1291 1312 1289 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="CR2" ref-type="bibr">Materials and methods</xref>
###xml 1316 1317 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1328 1329 1326 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1589 1590 1585 1586 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1652 1653 1646 1647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 898 1654 898 1648 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Percentage inhibition of anti-IgE-activated CD203c expression in human basophils treated with high histamine dilutions (<bold>a</bold>) or with high water dilutions (<bold>b</bold>). Mean&#160;&#177;&#160;SEM percentages from five experiments in (<bold>a</bold>) and from five experiments in (<bold>b</bold>) were calculated after subtracting the constitutive fluorescence of resting cells from the fluorescence of anti-IgE-activated cells, as described in &#8220;<xref rid="CR2" ref-type="bibr">Materials and methods</xref>&#8221;. *<italic>P</italic>&#160;&lt;&#160;0.05, **<italic>P</italic>&#160;&lt;&#160;0.01 (two-tailed Wilcoxon test for paired data, comparing histamine or water dilutions with the mean of untreated controls in each experiment). CD203c MFI values of the uninhibited activation were 2576.6&#160;&#177;&#160;543.3 SEM in the histamine dilution experiments (<bold>a</bold>) and 4142.1&#160;&#177;&#160;348.4 SEM in the water dilution experiments (<bold>b</bold>)</p>
###xml 898 1654 898 1648 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43">Percentage inhibition of anti-IgE-activated CD203c expression in human basophils treated with high histamine dilutions (<bold>a</bold>) or with high water dilutions (<bold>b</bold>). Mean&#160;&#177;&#160;SEM percentages from five experiments in (<bold>a</bold>) and from five experiments in (<bold>b</bold>) were calculated after subtracting the constitutive fluorescence of resting cells from the fluorescence of anti-IgE-activated cells, as described in &#8220;<xref rid="CR2" ref-type="bibr">Materials and methods</xref>&#8221;. *<italic>P</italic>&#160;&lt;&#160;0.05, **<italic>P</italic>&#160;&lt;&#160;0.01 (two-tailed Wilcoxon test for paired data, comparing histamine or water dilutions with the mean of untreated controls in each experiment). CD203c MFI values of the uninhibited activation were 2576.6&#160;&#177;&#160;543.3 SEM in the histamine dilution experiments (<bold>a</bold>) and 4142.1&#160;&#177;&#160;348.4 SEM in the water dilution experiments (<bold>b</bold>)</p></caption>
###xml 1654 1654 1648 1648 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11_2009_44_Fig2_HTML" id="MO3"/>
###xml 892 1654 892 1648 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="43">Percentage inhibition of anti-IgE-activated CD203c expression in human basophils treated with high histamine dilutions (<bold>a</bold>) or with high water dilutions (<bold>b</bold>). Mean&#160;&#177;&#160;SEM percentages from five experiments in (<bold>a</bold>) and from five experiments in (<bold>b</bold>) were calculated after subtracting the constitutive fluorescence of resting cells from the fluorescence of anti-IgE-activated cells, as described in &#8220;<xref rid="CR2" ref-type="bibr">Materials and methods</xref>&#8221;. *<italic>P</italic>&#160;&lt;&#160;0.05, **<italic>P</italic>&#160;&lt;&#160;0.01 (two-tailed Wilcoxon test for paired data, comparing histamine or water dilutions with the mean of untreated controls in each experiment). CD203c MFI values of the uninhibited activation were 2576.6&#160;&#177;&#160;543.3 SEM in the histamine dilution experiments (<bold>a</bold>) and 4142.1&#160;&#177;&#160;348.4 SEM in the water dilution experiments (<bold>b</bold>)</p></caption><graphic position="anchor" xlink:href="11_2009_44_Fig2_HTML" id="MO3"/></fig>
###xml 963 968 <span type="species:ncbi:9606">human</span>
Figure 2 reports the percentage inhibition by histamine and control water across the range of high dilutions tested on CD203c expression (MFI). Preliminary experiments showed that histamine (low and high dilutions) did not affect the resting MFI but only the activation response. So the percentage effect was calculated not on the absolute values, but only on the net MFI after subtracting the resting MFI. Histamine 2C (positive control) inhibition was 60.91% (P < 0.01) and 59.43% (P < 0.01) in the experiments testing histamine and water dilutions, respectively. There was no significant difference between the inhibition by histamine 2C in the two series. The dilution-effect histogram of histamine (A) shows a non-linear behaviour, with peaks at 14C and 16C dilution and paradoxically less activity at lower dilutions. No significant effects of water control dilutions (B) were observed.Fig. 2Percentage inhibition of anti-IgE-activated CD203c expression in human basophils treated with high histamine dilutions (a) or with high water dilutions (b). Mean +/- SEM percentages from five experiments in (a) and from five experiments in (b) were calculated after subtracting the constitutive fluorescence of resting cells from the fluorescence of anti-IgE-activated cells, as described in "Materials and methods". *P < 0.05, **P < 0.01 (two-tailed Wilcoxon test for paired data, comparing histamine or water dilutions with the mean of untreated controls in each experiment). CD203c MFI values of the uninhibited activation were 2576.6 +/- 543.3 SEM in the histamine dilution experiments (a) and 4142.1 +/- 348.4 SEM in the water dilution experiments (b)
###end p 42
###begin p 43
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 208 209 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 241 242 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 393 414 391 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="CR2" ref-type="bibr">Materials and methods</xref>
###xml 418 419 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 430 431 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 691 692 687 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 754 755 748 749 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Percentage inhibition of anti-IgE-activated CD203c expression in human basophils treated with high histamine dilutions (a) or with high water dilutions (b). Mean +/- SEM percentages from five experiments in (a) and from five experiments in (b) were calculated after subtracting the constitutive fluorescence of resting cells from the fluorescence of anti-IgE-activated cells, as described in "Materials and methods". *P < 0.05, **P < 0.01 (two-tailed Wilcoxon test for paired data, comparing histamine or water dilutions with the mean of untreated controls in each experiment). CD203c MFI values of the uninhibited activation were 2576.6 +/- 543.3 SEM in the histamine dilution experiments (a) and 4142.1 +/- 348.4 SEM in the water dilution experiments (b)
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human basophils are peripheral granulocytes involved in immune and inflammatory processes such as hypersensitivity and allergic reactions. The discovery of several basophil activation markers, such as the tetraspanin CD63 (lysosome-associated membrane protein or LAMP-3) and the ectoenzyme CD203c (or ecto-nucleotide pyrophosphatase/phosphodiesterase or E-NPP3), has made it possible to study cellular function by observing the up-regulation or down-regulation of membrane molecules in response to various physiological agonists, antagonists or other soluble regulators [34, 35], using a standardized cytometric approach.
###end p 45
###begin p 46
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
Among the various soluble factors able to regulate basophil function, a considerable body of literature has been devoted to histamine, a well-known mediator of inflammation produced by basophils and mast cells. Histamine at high doses acts as a downstream regulator by interacting with H2-receptors, thus inhibiting basophil release of mediators and degranulation [36]; it is therefore very intriguing that the same effect was observed with highly diluted histamine but not with highly diluted histidine [11], and that it could be inhibited by the H2-antagonist cimetidine [37]. Multicentre analyses have partially confirmed these findings [10], but other groups also report some negative results [19].
###end p 46
###begin p 47
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
In this work we were able to reproduce evidence for the effects of high histamine dilutions on anti-IgE-triggered basophil activation, specifically evaluated by the CD203 MFI, using a standardized approach with the following characteristics: (a) the method of cell handling prevents spontaneous basophil activation and interference between the anti-IgE-FITC tracer and the agonist used [14]; (b) the problems of subjective evaluation are avoided through use of flow cytometry and a system of multiple intra-series replication; (c) use of highly pure compounds and parallel comparisons with control pure water dilutions; d) adoption, for the first time in this field, of a mechanical shaking method (succussion in homeopathic terms) with standardized duration and frequency of strokes.
###end p 47
###begin p 48
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
The resultant dose-effect curve displayed a very unusual behaviour, whose underlying mechanism remains to be investigated. It is worth noting that the range of active dilutions is very close to the 16C dilution reported elsewhere [11, 15], although Brown and Ennis [13] instead reported inhibitory activities for 10C and 13C, but not for the 12C, 14C and 16C dilutions.
###end p 48
###begin p 49
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 817 818 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
The lack of significant inhibition of CD63 expression by histamine at high dilutions in our experimental conditions (Table 2) may apparently be in disagreement with the data of CD203c and with the findings of other authors who detected high-dilution effects also using CD63 marker [11]. However, this discrepancy may be interpreted as due to the lower sensitivity of this parameter to inhibition by high dilutions or otherwise as a result of the high variability of this response, because of the low percentage of cells expressing CD63 in our test system. In this study we chose to use low doses of agonist, a condition in which cells were consistently activated, as noted by the increase of CD203c MFI, but very low percentage (8-15%) of cells expressed CD63, which is less responsive to low doses of anti-IgE (Fig. 1a). As a consequence, the high-dilution effects were much more clearly and consistently observable by evaluating the CD203c marker. We have previously shown that the chemotactic peptide fMLP, at very low dose, causes up-regulation of CD203c but not of CD63 [26], and this observation is consistent with the finding that CD203c reflects the priming events triggered by interleukin-3, which occur previously to degranulation events [28]. Moreover, CD203c expression in not inhibited by phosphatidylinositol-3-kinase inhibitors, as is CD63 [29]. Thus, small changes in the experimental conditions used or subtle distinction of the signal transduction mechanisms of the two markers expression could differentiate the results of high dilution experiments obtained by different authors in this model.
###end p 49
###begin p 50
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
Although a variety of gating protocols and different experimental conditions-in terms of the type of dilution/succussion or shaking procedures and solvent used-have been explored [13, 38], most of the studies done so far did not include succussed water controls. Research on extremely sensitive systems and very high dilutions of substances suggests that trace elements, as well as container materials, storage durations and shaking methods, may influence the results [39]. Therefore, suitable water controls prepared in an identical manner and subjected to the same storage time should be used. These considerations, coupled with the highly controversial nature of the phenomenon, which would have significant pharmacological implications but is often judged to be improbable and implausible from a conventional scientific perspective [24, 40, 41], make it all the more important that more replications should be done independently to establish models that are stable across laboratories and teams [22].
###end p 50
###begin p 51
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 1158 1163 <span type="species:ncbi:9606">human</span>
The possible biological mechanism(s) underlying the regulatory processes affected by high histamine dilutions remain to be elucidated. These findings suggest that the high dilutions of histamine, which are better observed through CD203c expression, might affect some subtle and early level of signal transduction, similar to the priming effects of very low doses, instead of causing a general inhibition of cell responses. Using a surface plasmon resonance biosensor, it has recently been shown that basophil activation by anti-IgE, even in the absence of exocytosis, is associated with changes in the refractive index of the evanescent field [42]; such changes reflect any changes in molecular mass distribution in the field a few 100 nm from the surface of the cells. It is thus tempting to speculate that changes in the water structure produced by the dilution/succussion procedure in the presence of histamine might influence this crucial layer of water surrounding the cell and hence the processes of signal detection and transduction. Further studies are needed to confirm whether this hypothesis is applicable to the high-dilution effects observed on human basophils.
###end p 51
###begin p 52
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">45</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">48</xref>
###xml 866 869 866 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;20</sup>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">49</xref>
###xml 1613 1615 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">50</xref>
Our results confirm and build upon the hypothesis that high dilutions of biologically active compounds may indeed have an effect which mimics that of lower dilutions/higher doses. So far there is no satisfactory or uniting theoretical explanation for these observations, but recent evidence seems to point to organization of the solvent water on a mesoscopic scale: the nano-heterogenous structure of water can be determined by interactive phenomena such as coherence [43, 44], epitaxy [45], temperature-pressure processes during strong agitation, and formation of colloidal nanobubbles containing gaseous inclusions of oxygen, nitrogen, carbon dioxide, silica, and possibly the remedy source material [46-48]. So far, nuclear magnetic resonance (NMR) studies of homeopathic solutions have yielded controversial data, but recently high histamine dilutions (beyond 10-20 mol/l) were distinguished from water solvents on the basis of their NMR relaxation rates [49]; moreover, after heating of the histamine samples, all the relaxation observed as a function of dilution vanished. It was suggested that histamine molecules might act as nucleation centres, amplifying the formation of stable supramolecular structures, involving nanobubbles of atmospheric gases and highly ordered water around them. In the future, the possible existence and the nature of clathrate-like hydrate nanostructures formed during the dilution and succussion process might be explained by cluster science, in which different geometrical structures of clusters composed of the same chemical species may differ in their chemical reactivity [50]. These unusual properties of high dilutions, which merit further investigation, are potentially relevant not just to homeopathic pharmaceutical practice, but also to basic research into cell sensitivity to regulation.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
The study was financed by a grant from Laboratories Boiron srl, Milano (Italy), and in part by the Italian Ministry of Education, University and Research (60% funds). The authors wish to thank Dr Luigi Marrari for his advice and cooperation.
###end p 54
###begin p 55
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Immunology and homeopathy. 2. Cells of the immune system and inflammation
###end article-title 57
###begin article-title 58
Immunology and homeopathy. 3. Experimental studies on animal models
###end article-title 58
###begin article-title 59
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human basophil degranulation triggered by very dilute antiserum against IgE
###end article-title 59
###begin article-title 60
"High-dilution" experiments a delusion
###end article-title 60
###begin article-title 61
Mechanical agitation of very dilute antiserum against IgE has no effect on basophil staining properties
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Human basophil degranulation is not triggered by very dilute antiserum against human IgE
###end article-title 62
###begin article-title 63
E'tude mathematique et statistique des effets de dilutions successives de chlorhydrate d'histamine sur la reactivite des basophiles humains
###end article-title 63
###begin article-title 64
###xml 84 89 <span type="species:ncbi:9606">human</span>
Biological activity of ultra low doses I. Effect of ultra low doses of histamine on human basophil degranulation triggered by D. pteronissinus extract
###end article-title 64
###begin article-title 65
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human basophil activation by high dilutions of histamine
###end article-title 65
###begin article-title 66
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human basophil degranulation by successive histamine dilutions: results of a European multi-centre trial
###end article-title 66
###begin article-title 67
Histamine dilutions modulate basophil activation
###end article-title 67
###begin article-title 68
###xml 75 80 <span type="species:ncbi:9606">human</span>
Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry
###end article-title 68
###begin article-title 69
Flow-cytometric analysis of basophil activation: inhibition by histamine at conventional and homeopathic concentrations
###end article-title 69
###begin article-title 70
Sensitive flow cytometric method to test basophil activation influenced by homeopathic histamine dilutions
###end article-title 70
###begin article-title 71
###xml 68 73 <span type="species:ncbi:9606">human</span>
Use of four different flow cytometric protocols for the analysis of human basophil activation. Application to the study of the biological activity of high dilutions
###end article-title 71
###begin article-title 72
###xml 143 148 <span type="species:ncbi:9606">human</span>
Confirmation of biological effects of high dilutions. Effects of submolecular concentrations of histamine and 1-, 3- and 4-methylhistamines on human basophil activation
###end article-title 72
###begin article-title 73
Improvement of flow cytometric analysis of basophil activation inhibition by high histamine dilutions. A novel basophil specific marker: CD 203c
###end article-title 73
###begin article-title 74
###xml 67 72 <span type="species:ncbi:9606">human</span>
Stimulatory effect of high dilutions of histamine on activation of human basophils induced by anti-IgE
###end article-title 74
###begin article-title 75
###xml 82 87 <span type="species:ncbi:9606">human</span>
Replication study concerning the effects of homeopathic dilutions of histamine on human basophil degranulation in vitro
###end article-title 75
###begin article-title 76
Critical review and meta-analysis of serial agitated dilutions in experimental toxicology
###end article-title 76
###begin article-title 77
A critical overview of homeopathy
###end article-title 77
###begin article-title 78
The in vitro evidence for an effect of high homeopathic potencies-a systematic review of the literature
###end article-title 78
###begin article-title 79
The in vitro evidence for an effect of high homeopathic potencies-a systematic review of the literature
###end article-title 79
###begin article-title 80
A debate: homeopathy-quackery or a key to the future of medicine?
###end article-title 80
###begin article-title 81
Homeopathy and high dilutions-is there a real effect?
###end article-title 81
###begin article-title 82
###xml 25 30 <span type="species:ncbi:9606">human</span>
Differential response of human basophil activation markers: a multi-parameter flow cytometry approach
###end article-title 82
###begin article-title 83
Assays for measuring in vitro basophil activation induced by recombinant allergens
###end article-title 83
###begin article-title 84
Marked improvement of the basophil activation test by detecting CD203c instead of CD63
###end article-title 84
###begin article-title 85
###xml 26 31 <span type="species:ncbi:9606">human</span>
Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls
###end article-title 85
###begin article-title 86
###xml 142 145 <span type="species:ncbi:9685">cat</span>
Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy
###end article-title 86
###begin article-title 87
Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial
###end article-title 87
###begin article-title 88
Immunophenotypic study of basophils by multiparameter flow cytometry
###end article-title 88
###begin article-title 89
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Basophil activation during pollen season in patients monosensitized to grass pollens
###end article-title 89
###begin article-title 90
###xml 11 16 <span type="species:ncbi:9606">human</span>
Monitoring human basophil activation via CD63 monoclonal antibody 435
###end article-title 90
###begin article-title 91
The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis
###end article-title 91
###begin article-title 92
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells
###end article-title 92
###begin article-title 93
###xml 104 109 <span type="species:ncbi:9606">human</span>
Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil activation: effect of cimetidine
###end article-title 93
###begin article-title 94
Influence of the diluent on the effect of highly diluted histamine on basophil activation
###end article-title 94
###begin article-title 95
The role of trace elements in homeopathic preparations and the influence of container material, storage duration, and potentisation
###end article-title 95
###begin article-title 96
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy
###end article-title 96
###begin article-title 97
On the plausibility of homeopathy
###end article-title 97
###begin article-title 98
###xml 77 82 <span type="species:ncbi:9606">human</span>
Applying surface plasmon resonance to Monitor the IgE-mediated activation of human basophils
###end article-title 98
###begin article-title 99
Coherence electrodynamics in water
###end article-title 99
###begin article-title 100
Quanta and coherence effects in water and living systems
###end article-title 100
###begin article-title 101
The defining role of structure (including epitaxy) in the plausibility of homeopathy
###end article-title 101
###begin article-title 102
Low-field NMR water proton longitudinal relaxation in ultrahighly diluted aqueous solutions of silica-lactose prepared in glass material for pharmaceutical use
###end article-title 102
###begin article-title 103
The memory of water: an overview
###end article-title 103
###begin article-title 104
The structure of liquid water. Novel insights from materials research; potential relevance to homeopathy
###end article-title 104

